Literature DB >> 17824954

Vaccines against malaria - an update.

Kai Matuschewski1, Ann-Kristin Mueller.   

Abstract

Malaria vaccine discovery and development follow two principal strategies. Most subunit vaccines are designed to mimic naturally acquired immunity that develops over years upon continuous exposure to Plasmodium transmission. Experimental model vaccines, such as attenuated live parasites and transmission-blocking antigens, induce immune responses superior to naturally acquired immunity. The promises and hurdles of the different tracks towards an effective and affordable vaccine against malaria are discussed.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17824954     DOI： 10.1111/j.1742-4658.2007.05998.x

Source DB:  PubMed          Journal:  FEBS J        ISSN： 1742-464X            Impact factor:   5.542


  12 in total

Review 1.  Reflections on early malaria vaccine studies, the first successful human malaria vaccination, and beyond.

Authors:  Jerome P Vanderberg
Journal:  Vaccine       Date:  2008-10-28       Impact factor: 3.641

Review 2.  Vaccines against malaria.

Authors:  Amed Ouattara; Matthew B Laurens
Journal:  Clin Infect Dis       Date:  2014-12-01       Impact factor: 9.079

3.  Protein-DNA complex is the exclusive malaria parasite component that activates dendritic cells and triggers innate immune responses.

Authors:  Xianzhu Wu; Nagaraj M Gowda; Sanjeev Kumar; D Channe Gowda
Journal:  J Immunol       Date:  2010-03-15       Impact factor: 5.422

4.  Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.

Authors:  D Lys Guilbride; Pawel Gawlinski; Patrick D L Guilbride
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

5.  Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine.

Authors:  Amed Ouattara; Jianbing Mu; Shannon Takala-Harrison; Renion Saye; Issaka Sagara; Alassane Dicko; Amadou Niangaly; Junhui Duan; Ruth D Ellis; Louis H Miller; Xin-zhuan Su; Christopher V Plowe; Ogobara K Doumbo
Journal:  Malar J       Date:  2010-06-21       Impact factor: 2.979

6.  Using decision analysis to improve malaria control policy making.

Authors:  Randall A Kramer; Katherine L Dickinson; Richard M Anderson; Vance G Fowler; Marie Lynn Miranda; Clifford M Mutero; Kathryn A Saterson; Jonathan B Wiener
Journal:  Health Policy       Date:  2009-04-07       Impact factor: 2.980

7.  Plasmodium falciparum-specific cellular immune responses after immunization with the RTS,S/AS02D candidate malaria vaccine in infants living in an area of high endemicity in Mozambique.

Authors:  Arnoldo Barbosa; Denise Naniche; John J Aponte; M Nelia Manaca; Inacio Mandomando; Pedro Aide; Jahit Sacarlal; Montse Renom; Sarah Lafuente; W Ripley Ballou; Pedro L Alonso
Journal:  Infect Immun       Date:  2009-08-03       Impact factor: 3.441

Review 8.  Malaria vaccines: looking back and lessons learnt.

Authors:  Veronique Lorenz; Panagiotis Karanis
Journal:  Asian Pac J Trop Biomed       Date:  2011-01

9.  Protective efficacy and safety of liver stage attenuated malaria parasites.

Authors:  Hirdesh Kumar; Julia Magdalena Sattler; Mirko Singer; Kirsten Heiss; Miriam Reinig; Christiane Hammerschmidt-Kamper; Volker Heussler; Ann-Kristin Mueller; Friedrich Frischknecht
Journal:  Sci Rep       Date:  2016-05-31       Impact factor: 4.379

10.  A mathematical model of the impact of present and future malaria vaccines.

Authors:  Edward A Wenger; Philip A Eckhoff
Journal:  Malar J       Date:  2013-04-15       Impact factor: 2.979
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.